The impact of disease activity and interferon-α on the nervous system in systemic lupus erythematosus
The study suggests that disease activity and IFN-α may drive neuronal affliction in SLE, also in the absence of overt neuropsychiatric symptoms, and that controlling disease activity could improve the cerebral outcome.
Authors
- Petrus Linge
- Andreas Jönsen (ORCID: https://orcid.org/0000-0002-4418-5786)
- Oskar Hansson (ORCID: https://orcid.org/0000-0001-8467-7286)
- Kristoffer A. Zervides (ORCID: https://orcid.org/0000-0003-4311-1635)
- Jessika Nystedt (ORCID: https://orcid.org/0000-0002-7193-1828)
- Pia C. Sundgren (ORCID: https://orcid.org/0000-0001-9237-1236)
- Shorena Janelidze (ORCID: https://orcid.org/0000-0003-2869-8378)
- Elsa Grenmyr (ORCID: https://orcid.org/0009-0001-2638-401X)
- Anders Bengtsson (ORCID: https://orcid.org/0000-0001-7752-0432)
- Petra C Nilsson
Institutions
- Lund University (SE)
- Skåne University Hospital (SE)
Publication Details
- Journal
- Arthritis Research & Therapy
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1186/s13075-025-03539-2
- Citations
- 10
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 16.68
Funders
- Lunds Universitet
- Greta och Johan Kocks stiftelser
- Reumatikerförbundet
- Skånes universitetssjukhus